1. Apelqvist J. Diagnostics and treatment of the diabetic foot. Endocrine. 2012; 41:384–97.
Article
2. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017; 49:106–16.
Article
3. Mishra SC, Chhatbar KC, Kashikar A, Mehndiratta A. Diabetic foot. BMJ. 2017; 359:j5064.
Article
4. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003; 26:1435–8.
5. Reiber GE. The epidemiology of diabetic foot problems. Diabet Med. 1996; 13 Suppl 1:S6–11.
Article
6. Jeffcoate WJ, Price PE, Phillips CJ, Game FL, Mudge E, Davies S, et al. Randomised controlled trial of the use of three dressing preparations in the management of chronic ulceration of the foot in diabetes. Health Technol Assess. 2009; 13:1–86.
Article
7. Ragnarson Tennvall G, Apelqvist J. Health-related quality of life in patients with diabetes mellitus and foot ulcers. J Diabetes Complications. 2000; 14:235–41.
Article
8. Kerr M, Rayman G, Jeffcoate WJ. Cost of diabetic foot disease to the National Health Service in England. Diabet Med. 2014; 31:1498–504.
Article
9. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017; 376:2367–75.
Article
10. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system: the contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care. 1998; 21:855–9.
Article
11. Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care. 2003; 26:491–4.
Article
12. Ikonen TS, Sund R, Venermo M, Winell K. Fewer major amputations among individuals with diabetes in Finland in 1997-2007: a population-based study. Diabetes Care. 2010; 33:2598–603.
13. Ragnarson Tennvall G, Apelqvist J. Health-economic consequences of diabetic foot lesions. Clin Infect Dis. 2004; 39 Suppl 2:S132–9.
Article
14. Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons NB. Burden of diabetic foot ulcers for medicare and private insurers. Diabetes Care. 2014; 37:651–8.
Article
15. Apelqvist J, Ragnarson-Tennvall G, Persson U, Larsson J. Diabetic foot ulcers in a multidisciplinary setting: an economic analysis of primary healing and healing with amputation. J Intern Med. 1994; 235:463–71.
Article
16. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005; 366:1719–24.
Article
17. Monteiro-Soares M, Boyko EJ, Ribeiro J, Ribeiro I, DinisRibeiro M. Predictive factors for diabetic foot ulceration: a systematic review. Diabetes Metab Res Rev. 2012; 28:574–600.
Article
18. Parisi MC, Moura Neto A, Menezes FH, Gomes MB, Teixeira RM, de Oliveira JE, et al. Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study. Diabetol Metab Syndr. 2016; 8:25.
Article
19. Papanas N, Maltezos E. Glycated hemoglobin as a risk factor for lower extremity amputations in diabetes: “success is counted sweetest”. Int J Low Extrem Wounds. 2015; 14:106–7.
20. Lee J, Lee JS, Park SH, Shin SA, Kim K. Cohort profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2017; 46:e15.
Article
21. Yang HK, Han K, Kwon HS, Park YM, Cho JH, Yoon KH, et al. Obesity, metabolic health, and mortality in adults: a nationwide population-based study in Korea. Sci Rep. 2016; 6:30329.
Article
22. Bae EH, Lim SY, Jung JH, Oh TR, Choi HS, Kim CS, et al. Chronic kidney disease risk of isolated systolic or diastolic hypertension in young adults: a nationwide sample basedcohort study. J Am Heart Assoc. 2021; 10:e019764.
Article
23. Gulliford MC, Mahabir D. Diabetic foot disease and foot care in a Caribbean community. Diabetes Res Clin Pract. 2002; 56:35–40.
Article
24. Adler AI, Boyko EJ, Ahroni JH, Smith DG. Lower-extremity amputation in diabetes: the independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care. 1999; 22:1029–35.
Article
25. Riaz M, Miyan Z, Zaidi SI, Alvi SF, Fawwad A, Ahmadani MY, et al. Characteristics of a large cohort of patients with diabetes having at-risk feet and outcomes in patients with foot ulceration referred to a tertiary care diabetes unit. Int Wound J. 2016; 13:594–9.
Article
26. Tseng CH. Prevalence and risk factors of diabetic foot problems in Taiwan: a cross-sectional survey of non-type 1 diabetic patients from a nationally representative sample. Diabetes Care. 2003; 26:3351.
27. Iversen MM, Tell GS, Riise T, Hanestad BR, Ostbye T, Graue M, et al. History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trondelag Health Study, Norway. Diabetes Care. 2009; 32:2193–9.
28. Bus SA, van Deursen RW, Armstrong DG, Lewis JE, Caravaggi CF, Cavanagh PR, et al. Footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in patients with diabetes: a systematic review. Diabetes Metab Res Rev. 2016; 32 Suppl 1:99–118.
Article
29. Ward R, Dunn J, Clavijo L, Shavelle D, Rowe V, Woo K. Outcomes of critical limb ischemia in an urban, safety net hospital population with high WIfI amputation scores. Ann Vasc Surg. 2017; 38:84–9.
Article
30. Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med. 1993; 233:485–91.
Article
31. Lazzarini PA, Hurn SE, Fernando ME, Jen SD, Kuys SS, Kamp MC, et al. Prevalence of foot disease and risk factors in general inpatient populations: a systematic review and meta-analysis. BMJ Open. 2015; 5:e008544.
Article
32. Holman N, Young RJ, Jeffcoate WJ. Variation in the recorded incidence of amputation of the lower limb in England. Diabetologia. 2012; 55:1919–25.
Article
33. Liu M, Zhang W, Yan Z, Yuan X. Smoking increases the risk of diabetic foot amputation: a meta-analysis. Exp Ther Med. 2018; 15:1680–5.
Article
34. Lakier JB. Smoking and cardiovascular disease. Am J Med. 1992; 93(1A):8S–12S.
Article
35. Kourembanas S, Marsden PA, McQuillan LP, Faller DV. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest. 1991; 88:1054–7.
Article
36. Lee FS. Genetic causes of erythrocytosis and the oxygensensing pathway. Blood Rev. 2008; 22:321–32.
Article
37. Ben G, Gnudi L, Maran A, Gigante A, Duner E, Iori E, et al. Effects of chronic alcohol intake on carbohydrate and lipid metabolism in subjects with type II (non-insulin-dependent) diabetes. Am J Med. 1991; 90:70–6.
Article
38. Pal B, Raveender N, Sudipta P. A study on the impact of smoking and alcoholism as determinant factors in the prognosis and outcome of diabetic foot ulcer disease. Int J Res Med Sci. 2016; 4:1720–4.
Article
39. Matos M, Mendes R, Silva AB, Sousa N. Physical activity and exercise on diabetic foot related outcomes: a systematic review. Diabetes Res Clin Pract. 2018; 139:81–90.
Article
40. Sartor CD, Hasue RH, Cacciari LP, Butugan MK, Watari R, Passaro AC, et al. Effects of strengthening, stretching and functional training on foot function in patients with diabetic neuropathy: results of a randomized controlled trial. BMC Musculoskelet Disord. 2014; 15:137.
Article
41. Tran MM, Haley MN. Does exercise improve healing of diabetic foot ulcers?: a systematic review. J Foot Ankle Res. 2021; 14:19.
Article
42. Ang L, Jaiswal M, Martin C, Pop-Busui R. Glucose control and diabetic neuropathy: lessons from recent large clinical trials. Curr Diab Rep. 2014; 14:528.
Article
43. Balducci S, Iacobellis G, Parisi L, Di Biase N, Calandriello E, Leonetti F, et al. Exercise training can modify the natural history of diabetic peripheral neuropathy. J Diabetes Complications. 2006; 20:216–23.
Article
44. Ahn S, Song R. Effects of Tai Chi exercise on glucose control, neuropathy scores, balance, and quality of life in patients with type 2 diabetes and neuropathy. J Altern Complement Med. 2012; 18:1172–8.
Article
45. Lemaster JW, Mueller MJ, Reiber GE, Mehr DR, Madsen RW, Conn VS. Effect of weight-bearing activity on foot ulcer incidence in people with diabetic peripheral neuropathy: feet first randomized controlled trial. Phys Ther. 2008; 88:1385–98.
Article
46. Moura Neto A, Zantut-Wittmann DE, Fernandes TD, Nery M, Parisi MC. Risk factors for ulceration and amputation in diabetic foot: study in a cohort of 496 patients. Endocrine. 2013; 44:119–24.
Article
47. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care. 2000; 23:606–11.
Article
48. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer: the Seattle Diabetic Foot Study. Diabetes Care. 1999; 22:1036–42.
Article
49. Sohn MW, Budiman-Mak E, Lee TA, Oh E, Stuck RM. Significant J-shaped association between body mass index (BMI) and diabetic foot ulcers. Diabetes Metab Res Rev. 2011; 27:402–9.
Article
50. Li X, Xiao T, Wang Y, Gu H, Liu Z, Jiang Y, et al. Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospital. Diabetes Res Clin Pract. 2011; 93:26–30.
Article